Covered recipient · General Payments record
SAMANTHA R ADKINS
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$1,247.27
- Reported across 67 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $446.35 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $157.81 | 8 |
| Paragon 28, Inc. | $148.16 | 1 |
| E.R. Squibb & Sons, L.L.C. | $47.49 | 3 |
| GlaxoSmithKline, LLC. | $30.58 | 2 |
| Lilly USA, LLC | $22.12 | 1 |
| Acerta Pharma LLC | $13.44 | 1 |
| Abbott Laboratories | $13.39 | 1 |
| Novo Nordisk AS | $13.36 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $13.39 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125002172 | CMS |
| ABBVIE INC. | $30.56 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106414687 | CMS |
| ABBVIE INC. | $16.82 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106414689 | CMS |
| ABBVIE INC. | $28.14 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106414691 | CMS |
| ABBVIE INC. | $30.39 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106414693 | CMS |
| ABBVIE INC. | $3.60 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106414695 | CMS |
| ABBVIE INC. | $20.70 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106414697 | CMS |
| ABBVIE INC. | $16.12 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106414699 | CMS |
| ABBVIE INC. | $11.48 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106414701 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.44 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104756272 | CMS |
| E.R. Squibb & Sons, L.L.C. | $15.68 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101559235 | CMS |
| E.R. Squibb & Sons, L.L.C. | $15.23 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101559231 | CMS |
| E.R. Squibb & Sons, L.L.C. | $16.58 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101559257 | CMS |
| GlaxoSmithKline, LLC. | $15.19 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116690141 | CMS |
| GlaxoSmithKline, LLC. | $15.39 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116341256 | CMS |
| Lilly USA, LLC | $22.12 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135935776 | CMS |
| Novo Nordisk Inc | $13.36 | 06/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100279142 | CMS |
| Paragon 28, Inc. | $148.16 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138433781 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.